
Illumina (ILMN) is a leading diagnostics & research business based in the US. It opened the day at $214.28 after a previous close of $211.04. During the day the price has varied from a low of $210.27 to a high of $215.19. The latest price was $212.78 (25 minute delay). Illumina is listed on the NASDAQ and employs 9,800 staff. All prices are listed in US Dollars.
How to buy Illumina stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ILMN. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
- ILMN shares summary
- Compare share dealing platforms
- Is ILMN stock a buy or sell?
- Stock performance over time
- Is ILMN suitable for ethical investing?
- Are ILMN shares over-valued?
- Illumina's financials
- How volatile are ILMN shares?
- Does Illumina pay a dividend?
- Have ILMN shares ever split?
- Other common questions
Illumina stock price (NASDAQ: ILMN)
Use our graph to track the performance of ILMN stocks over time.Illumina shares at a glance
Open | $214.28 |
---|---|
High | $215.19 |
Low | $210.27 |
Close | $212.78 |
Previous close | $211.04 |
Change | $1.74 |
Change % | 0.8245% |
Volume | 671,672 |
52-week range | $173.45 - $371.16 |
---|---|
50-day moving average | $209.76 |
200-day moving average | $222.28 |
Wall St. target price | $243.17 |
PE ratio | 48.4572 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $4.44 |
Buy Illumina stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Illumina price performance over time
Historical closes compared with the close of $212.78 from 2023-01-25
1 week (2023-01-17) | 3.07% |
---|---|
1 month (2022-12-23) | 11.26% |
3 months (2022-10-26) | -10.35% |
6 months (2022-07-27) | 2.71% |
1 year (2022-01-27) | -34.40% |
---|---|
2 years (2021-01-27) | -50.75% |
3 years (2020-01-27) | 313.92 |
5 years (2018-01-26) | 244.83 |
Is Illumina stock undervalued or overvalued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's P/E ratio
Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, Illumina shares trade at around 48x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1783. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $570 million.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
Illumina financials
Revenue TTM | $4.7 billion |
---|---|
Operating margin TTM | 4.11% |
Gross profit TTM | $3.2 billion |
Return on assets TTM | 0.92% |
Return on equity TTM | -47.95% |
Profit margin | -88.36% |
Book value | $42.87 |
Market capitalisation | $33.8 billion |
TTM: trailing 12 months
Illumina's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Illumina's total ESG risk score
Total ESG risk: 9.18
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 12/31/2018) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Illumina's environmental score
Environmental score: 2.22/100
Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Illumina's social score
Social score: 2.6/100
Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Illumina's governance score
Governance score: 5.36/100
Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Illumina's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Illumina Inc was last rated for ESG on: 2019-01-01.
Total ESG score | 9.18 |
---|---|
Total ESG percentile | 2.42 |
Environmental score | 2.22 |
Environmental score percentile | 2 |
Social score | 2.6 |
Social score percentile | 2 |
Governance score | 5.36 |
Governance score percentile | 2 |
Level of controversy | 1 |
Illumina share dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's shares ever split?
Illumina's shares were split on a 2:1 basis on 22 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Illumina share price volatility
Over the last 12 months, Illumina's shares have ranged in value from as little as $173.45 up to $371.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 1.1318. This would suggest that Illumina's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Illumina overview
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Illumina in the news
What's in the Cards for Illumina (ILMN) in Q4 Earnings?
Sequencing the Sustainable Secrets of Seaweed
These 4 Toxic Stocks May Bring Bad Luck to Your Portfolio
Frequently asked questions
What percentage of Illumina is owned by insiders or institutions?Currently 0.347% of Illumina shares are held by insiders and 93.025% by institutions. How many people work for Illumina?
Latest data suggests 9,800 work at Illumina. When does the fiscal year end for Illumina?
Illumina's fiscal year ends in December. Where is Illumina based?
Illumina's address is: 5200 Illumina Way, San Diego, CA, United States, 92122 What is Illumina's ISIN number?
Illumina's international securities identification number is: US4523271090 What is Illumina's CUSIP number?
Illumina's Committee on Uniform Securities Identification Procedures number is: 452327109
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert